The latest update is out from Terns Pharmaceuticals ( ($TERN) ). Terns Pharmaceuticals has announced the appointment of Heather Turner, a seasoned biotechnology executive, to its Board of Directors as
The latest update is out from Terns Pharmaceuticals ( ($TERN) ). Terns Pharmaceuticals has announced the appointment of Heather Turner, a seasoned biotechnology executive, to its Board of Directors as
Terns Pharmaceuticals, Inc. ( ($TERN) ) has released its Q3 earnings. Here is a breakdown of the information Terns Pharmaceuticals, Inc. presented to its investors. Terns Pharmaceuticals, Inc. is a
TD Cowen analyst Ritu Baral has maintained their bullish stance on TERN stock, giving a Buy rating yesterday. Ritu Baral has given his Buy rating due to a combination of
Etzer Darout, an analyst from BMO Capital, has initiated a new Buy rating on Terns Pharmaceuticals (TERN). Etzer Darout’s rating is based on a combination of promising clinical developments and
In a report released today, Ed Arce from H.C. Wainwright maintained a Hold rating on Terns Pharmaceuticals (TERN – Research Report), with a price target of $7.50. Ed Arce’s rating